Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.

Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M.

Neurology. 2009 Oct 20;73(16):1333-4. doi: 10.1212/WNL.0b013e3181bd1344. No abstract available.

PMID:
19841387
2.

[Narcolepsy: a new perspective on diagnosis and treatment].

Fronczek R, van der Zande WL, van Dijk JG, Overeem S, Lammers GJ.

Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):856-61. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2007 Jun 2;151(22):1260.

PMID:
17472116
3.

[Narcolepsy--new implications of molecular biology].

Knudsen S, Jennum PJ.

Ugeskr Laeger. 2006 Oct 23;168(43):3699-704. Review. Danish.

PMID:
17069732
4.

Molecular genetics and treatment of narcolepsy.

Dauvilliers Y, Tafti M.

Ann Med. 2006;38(4):252-62. Review.

PMID:
16754256
5.

CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.

Arii J, Kanbayashi T, Tanabe Y, Sawaishi Y, Kimura S, Watanabe A, Mishima K, Hishikawa Y, Shimizu T, Nishino S.

Neurology. 2004 Dec 28;63(12):2440-2. Review. No abstract available.

PMID:
15623725
6.

Narcolepsy: a review of evidence for autoimmune diathesis.

Black JL 3rd.

Int Rev Psychiatry. 2005 Dec;17(6):461-9. Review.

PMID:
16401544
7.

Emerging drugs for narcolepsy.

Abad VC, Guilleminault C.

Expert Opin Emerg Drugs. 2004 Nov;9(2):281-91. Review.

PMID:
15571485
8.

Narcolepsy: pathophysiology and pharmacology.

Nishino S.

J Clin Psychiatry. 2007;68 Suppl 13:9-15. Review.

9.

[Moebius syndrome and narcolepsy].

Krämer S, Goldammer U, Sindern E.

Nervenarzt. 2014 Dec;85(12):1569-72. doi: 10.1007/s00115-014-4174-8. Review. German.

PMID:
25388761
10.

Novel therapies for narcolepsy.

Brooks S, Black J.

Expert Opin Investig Drugs. 2002 Dec;11(12):1821-7. Review.

PMID:
12457441
11.

Pediatric narcolepsy.

Peterson PC, Husain AM.

Brain Dev. 2008 Nov;30(10):609-23. doi: 10.1016/j.braindev.2008.02.004. Epub 2008 Mar 28. Review.

PMID:
18375081
12.

The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.

Nishino S.

Expert Opin Investig Drugs. 2007 Nov;16(11):1785-97. Review.

PMID:
17970638
13.

[Narcolepsy with cataplexy].

Dauvilliers Y, Arnulf I.

Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):634-45. doi: 10.1016/j.neurol.2007.08.012. Epub 2008 Mar 4. Review. French.

PMID:
18805301
14.

Successful treatment of narcolepsy and cataplexy: a review.

Lockrane B, Bhatia P, Gore R.

Can Respir J. 2005 May-Jun;12(4):225-7. Review.

PMID:
16003460
15.

[Orexin].

Sakurai T.

Nihon Rinsho. 2005 Aug;63 Suppl 8:600-2. Review. Japanese. No abstract available.

PMID:
16149587
16.

Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.

Fujiki N, Nishino S.

CNS Neurol Disord Drug Targets. 2007 Feb;6(1):45-62. Review.

PMID:
17305553
17.

[Narcolepsy].

Lange KW.

Dtsch Med Wochenschr. 1990 Aug 17;115(33):1244-50. Review. German. No abstract available.

PMID:
2201510
18.

[Advances in the diagnosis and treatment of narcolepsy-cataplexy syndrome].

de Vicente Alvarez-Manzaneda EE.

Rev Neurol. 2008 May 1-15;46(9):550-6. Review. Spanish.

19.

Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.

Mamelak M.

Prog Neurobiol. 2009 Oct;89(2):193-219. doi: 10.1016/j.pneurobio.2009.07.004. Epub 2009 Aug 3. Review.

PMID:
19654034
20.

Sodium oxybate for narcolepsy.

Scharf MB.

Expert Rev Neurother. 2006 Aug;6(8):1139-46. Review.

PMID:
16893342

Supplemental Content

Support Center